| Pure Wellness Of Smyrna, Llc | |
|
699 S Carter Rd Unit 5, Smyrna, DE 19977-7754 | |
| (302) 365-6520 | |
| (302) 365-6167 |
| Full Name | Pure Wellness Of Smyrna, Llc |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 699 S Carter Rd Unit 5, Smyrna, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295060622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | (* (Not Available)) | Primary |
| Provider Name | Kenneth M Decker |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1801933874 PECOS PAC ID: 1850378068 Enrollment ID: I20040706001073 |
News Archive
Remote Diagnostic Technologies Ltd., an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more.
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.
Leading healthcare advocates and civil justice groups today urged legislators and Governor Schwarzenegger to pass SB 726 (Ashburn), legislation that would expand and extend a pilot program under the Medical Board of California, allowing hospitals in rural and low-income communities to directly employ needed physicians.
In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.
› Verified 9 days ago
| Provider Name | Todd A Richardson |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1174634679 PECOS PAC ID: 7113976630 Enrollment ID: I20050121000346 |
News Archive
Remote Diagnostic Technologies Ltd., an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more.
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.
Leading healthcare advocates and civil justice groups today urged legislators and Governor Schwarzenegger to pass SB 726 (Ashburn), legislation that would expand and extend a pilot program under the Medical Board of California, allowing hospitals in rural and low-income communities to directly employ needed physicians.
In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.
› Verified 9 days ago
| Provider Name | Justin David Dietrich |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1598725715 PECOS PAC ID: 8426030644 Enrollment ID: I20050208000567 |
News Archive
Remote Diagnostic Technologies Ltd., an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more.
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.
Leading healthcare advocates and civil justice groups today urged legislators and Governor Schwarzenegger to pass SB 726 (Ashburn), legislation that would expand and extend a pilot program under the Medical Board of California, allowing hospitals in rural and low-income communities to directly employ needed physicians.
In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.
› Verified 9 days ago
| Provider Name | Patrick W Ward |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1699833749 PECOS PAC ID: 8022170901 Enrollment ID: I20081231000365 |
News Archive
Remote Diagnostic Technologies Ltd., an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more.
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.
Leading healthcare advocates and civil justice groups today urged legislators and Governor Schwarzenegger to pass SB 726 (Ashburn), legislation that would expand and extend a pilot program under the Medical Board of California, allowing hospitals in rural and low-income communities to directly employ needed physicians.
In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.
› Verified 9 days ago
| Provider Name | Eric C Marks |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1295740942 PECOS PAC ID: 6709893100 Enrollment ID: I20090223000526 |
News Archive
Remote Diagnostic Technologies Ltd., an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more.
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.
Leading healthcare advocates and civil justice groups today urged legislators and Governor Schwarzenegger to pass SB 726 (Ashburn), legislation that would expand and extend a pilot program under the Medical Board of California, allowing hospitals in rural and low-income communities to directly employ needed physicians.
In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.
› Verified 9 days ago
| Provider Name | Mark M Mauragas |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1508179185 PECOS PAC ID: 1355527672 Enrollment ID: I20110520000017 |
News Archive
Remote Diagnostic Technologies Ltd., an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more.
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.
Leading healthcare advocates and civil justice groups today urged legislators and Governor Schwarzenegger to pass SB 726 (Ashburn), legislation that would expand and extend a pilot program under the Medical Board of California, allowing hospitals in rural and low-income communities to directly employ needed physicians.
In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.
› Verified 9 days ago
| Provider Name | Rebecca A Leary |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1861754822 PECOS PAC ID: 9133384159 Enrollment ID: I20120626000036 |
News Archive
Remote Diagnostic Technologies Ltd., an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more.
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.
Leading healthcare advocates and civil justice groups today urged legislators and Governor Schwarzenegger to pass SB 726 (Ashburn), legislation that would expand and extend a pilot program under the Medical Board of California, allowing hospitals in rural and low-income communities to directly employ needed physicians.
In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.
› Verified 9 days ago
| Provider Name | Kelly A Brown |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1407109689 PECOS PAC ID: 6204050347 Enrollment ID: I20140612000117 |
News Archive
Remote Diagnostic Technologies Ltd., an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more.
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.
Leading healthcare advocates and civil justice groups today urged legislators and Governor Schwarzenegger to pass SB 726 (Ashburn), legislation that would expand and extend a pilot program under the Medical Board of California, allowing hospitals in rural and low-income communities to directly employ needed physicians.
In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.
› Verified 9 days ago
| Provider Name | Jessica L Cortellino |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1295225035 PECOS PAC ID: 4385909845 Enrollment ID: I20180604001533 |
News Archive
Remote Diagnostic Technologies Ltd., an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more.
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.
Leading healthcare advocates and civil justice groups today urged legislators and Governor Schwarzenegger to pass SB 726 (Ashburn), legislation that would expand and extend a pilot program under the Medical Board of California, allowing hospitals in rural and low-income communities to directly employ needed physicians.
In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.
› Verified 9 days ago
| Provider Name | Michael G Giambertone |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1881790905 PECOS PAC ID: 4789676701 Enrollment ID: I20181102000679 |
News Archive
Remote Diagnostic Technologies Ltd., an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more.
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.
Leading healthcare advocates and civil justice groups today urged legislators and Governor Schwarzenegger to pass SB 726 (Ashburn), legislation that would expand and extend a pilot program under the Medical Board of California, allowing hospitals in rural and low-income communities to directly employ needed physicians.
In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.
› Verified 9 days ago
| Provider Name | Vivian Giannakakis |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1053653097 PECOS PAC ID: 4486047388 Enrollment ID: I20220216001487 |
News Archive
Remote Diagnostic Technologies Ltd., an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more.
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.
Leading healthcare advocates and civil justice groups today urged legislators and Governor Schwarzenegger to pass SB 726 (Ashburn), legislation that would expand and extend a pilot program under the Medical Board of California, allowing hospitals in rural and low-income communities to directly employ needed physicians.
In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.
› Verified 9 days ago
| Provider Name | Brooke L Mazujian |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1154040780 PECOS PAC ID: 5193101947 Enrollment ID: I20220930001442 |
News Archive
Remote Diagnostic Technologies Ltd., an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more.
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.
Leading healthcare advocates and civil justice groups today urged legislators and Governor Schwarzenegger to pass SB 726 (Ashburn), legislation that would expand and extend a pilot program under the Medical Board of California, allowing hospitals in rural and low-income communities to directly employ needed physicians.
In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.
› Verified 9 days ago
| Provider Name | Shane P Hierlmaier |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1245930262 PECOS PAC ID: 0244605277 Enrollment ID: I20230405001407 |
News Archive
Remote Diagnostic Technologies Ltd., an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more.
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.
Leading healthcare advocates and civil justice groups today urged legislators and Governor Schwarzenegger to pass SB 726 (Ashburn), legislation that would expand and extend a pilot program under the Medical Board of California, allowing hospitals in rural and low-income communities to directly employ needed physicians.
In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pure Wellness Of Smyrna, Llc 550 Stanton Christiana Rd Ste 302, Newark, DE 19713-2132 Ph: (302) 365-6520 | Pure Wellness Of Smyrna, Llc 699 S Carter Rd Unit 5, Smyrna, DE 19977-7754 Ph: (302) 365-6520 |
News Archive
Remote Diagnostic Technologies Ltd., an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham. Lighter and more focused than existing technologies, the Tempus ALS enables paramedics to carry less and do much more.
A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.
Debiopharm International SA, part of Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.
Leading healthcare advocates and civil justice groups today urged legislators and Governor Schwarzenegger to pass SB 726 (Ashburn), legislation that would expand and extend a pilot program under the Medical Board of California, allowing hospitals in rural and low-income communities to directly employ needed physicians.
In a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes.
› Verified 9 days ago
Matthew Defroda, D.C Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1000 Smyrna Clayton Blvd Ste 3, Smyrna, DE 19977 Phone: 302-202-9926 | |
Brooke Mazujian, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 699 S Carter Rd Unit 5, Smyrna, DE 19977 Phone: 302-389-8915 | |
Delaware Back Pain & Sports Rehabilitation Centers Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 29 N East St, Smyrna, DE 19977 Phone: 302-389-2225 Fax: 302-389-1003 | |
Shane Peter Hierlmaier, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 699 S Carter Rd Unit 5, Smyrna, DE 19977 Phone: 302-389-8915 | |
Results Personal Training & Fitness Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1000 Smyrna Clayton Blvd Ste 1, Smyrna, DE 19977 Phone: 917-945-9406 | |
Hetal Chirag Patel, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 29 N East St, Smyrna, DE 19977 Phone: 302-389-2225 Fax: 302-389-1003 |